MARTINA, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 1.915
EU - Europa 675
AS - Asia 161
AF - Africa 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.758
Nazione #
US - Stati Uniti d'America 1.906
IT - Italia 152
IE - Irlanda 145
SE - Svezia 134
UA - Ucraina 85
SG - Singapore 54
DE - Germania 43
CN - Cina 35
FR - Francia 31
GB - Regno Unito 30
DK - Danimarca 26
TR - Turchia 25
IN - India 22
FI - Finlandia 16
KR - Corea 15
CA - Canada 9
BE - Belgio 8
JP - Giappone 6
RO - Romania 3
CI - Costa d'Avorio 2
GE - Georgia 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CL - Cile 1
EU - Europa 1
HK - Hong Kong 1
KG - Kirghizistan 1
PL - Polonia 1
SC - Seychelles 1
Totale 2.758
Città #
Chandler 367
Des Moines 322
Dublin 136
Ashburn 126
Fairfield 117
Jacksonville 101
New York 100
Wilmington 57
Lawrence 53
Princeton 53
Woodbridge 53
Boardman 52
Seattle 48
Houston 39
Cambridge 37
Centro 35
San Mateo 34
Turin 24
San Diego 22
Washington 18
Los Angeles 15
Redmond 14
Pune 13
London 12
Ann Arbor 11
Guangzhou 9
Toronto 9
Brussels 8
Norwalk 7
Beijing 5
Kolkata 5
Creazzo 4
Helsinki 4
Lunano 4
Boydton 3
Bucharest 3
Civitanova Marche 3
Florence 3
Hounslow 3
Jesi 3
Marche 3
New Bedfont 3
Trieste 3
Abidjan 2
Ancona 2
Andover 2
Chiswick 2
Guwahati 2
Hangzhou 2
Hanover 2
Kilburn 2
Macerata 2
Matera 2
Menlo Park 2
Milan 2
North Augusta 2
Parma 2
Rimini 2
Rome 2
San Casciano In Val Di Pesa 2
Shanghai 2
Tbilisi 2
Tokyo 2
Wandsworth 2
Acquaviva Picena 1
Acton 1
Adana 1
Ascoli Piceno 1
Auburn 1
Bellaria-Igea Marina 1
Bishkek 1
Brisbane 1
Casalecchio di Reno 1
Central 1
Genova 1
Laurel 1
Mahé 1
Monsampolo del Tronto 1
Montesilvano 1
Morrovalle 1
Naples 1
Novara 1
Osimo 1
Prescot 1
Redwood City 1
Riva 1
Somerville 1
Talca 1
Tolentino 1
Urbino 1
Vienna 1
Warsaw 1
Totale 2.011
Nome #
Adalimumab modulates angiogenesis in psoriatic skin 85
Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature 82
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 82
Hidradenitis suppurativa: How to treat with BoNT-A 78
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 77
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 76
Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial 75
Elastosis perforans serpiginosa: a case successfully treated with intralesional steroids and topical allium cepa-allantoin-pentaglycan gel 74
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review 74
Photoprotection and photodermatitis: a case 71
Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox? 68
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 68
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review 67
Skin Involvement in SARS-CoV-2 Infection: Case Series 66
"BOTULINUM TOXIN IN DERMATOLOGY: A CLINICAL OVERVIEW" 62
Safety update of etanercept treatment for moderate to severe plaque psoriasis 61
Buschke–ollendorff syndrome in a 6-year old patient: Clinical anhistopathological aspects of a rare disease 61
Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach. 60
It is never too late to treat chronic spontaneous urticaria with omalizumab: Real-life data from a multicenter observational study focusing on elderly patients 59
Role of small intestinal bacterial overgrowth and helicobacter pylori infection in chronic spontaneous urticaria: a prospective analysis 58
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 58
Botulinum Toxin Off-Label Use in Dermatology: A Review 57
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 57
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 57
Primary cutaneous large cell lymphoma CD30+: a case-based review 54
Modern electronic devices: An increasingly common cause of skin disorders in consumers 54
Myroxylon pereirae (balsam of Peru): Still worth testing? 53
Novel therapeutic approaches and targets for treatment of chronic urticaria: New insights and promising targets for a challenging disease 52
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities 51
VACCINATION AGAINST SARS-COV-2 and PSORIASIS: the three things every dermatologist should now 50
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 50
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 49
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 46
Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage 45
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 45
Topical application of fumaric acid esters improves appearance of nail psoriasis 42
Iperidrosi focale: novità terapeutiche 41
Omalizumab in Chronic Urticaria: An Italian Survey. 40
Saliva proteomics as fluid signature of inflammatory and immune mediated skin diseases 40
Acral Leukoderma: Is It Always Vitiligo? 37
Asymptomatic pigmentation of the skin in a child: babywipes, once again 36
Saliva and Oral Diseases 34
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 34
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 34
How to fight SARS-COV-2 vaccine hesitancy in patients suffering from chronic and immune-mediated skin disease: four general rules 32
Italian Guidelines in patch testing - Adapted from the European Society of Contact Dermatitis (ESCD) 32
Psoriasis as an immune-mediated and inflammatory systemic disease: From pathophysiology to novel therapeutic approaches 30
Contact allergy to hydrocortisone 21-acetate in Italy: A SIDAPA multicenter study 30
Late Patch Test Reaction to Acrylates in 2 Patients: Should We Schedule a Check at Weeks 2 and 3? 27
Infliximab-induced eruptive sebaceous hyperplasia in patient treated for ulcerative colitis: first reported case 26
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018–2019 25
A tricky case of contact dermatitis: Simultaneous allergic reaction to topical and oral acyclovir, and scar gel 21
Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study 19
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy 14
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside 13
Mesenchymal Stem Cells and Psoriasis: Systematic Review 13
Treatment of Axillary Bromhidrosis with Topical 2% Glycopyrronium Bromide Cream: A Prospective, Non-randomized, Open-label Study 13
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review 12
COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study 8
The Challenge Arising from New Knowledge about Immune and Inflammatory Skin Diseases: Where We Are Today and Where We Are Going 5
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature 5
The pharmacological treatment and management of hyperhidrosis 4
Totale 2.849
Categoria #
all - tutte 17.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 1 1
2019/2020141 7 0 16 6 23 1 19 8 21 10 3 27
2020/2021420 32 33 50 11 36 21 34 31 32 35 68 37
2021/2022409 8 56 12 2 35 15 9 31 23 12 121 85
2022/20231.180 78 119 63 97 52 419 0 48 204 5 77 18
2023/2024533 86 11 58 66 86 172 10 16 6 20 2 0
Totale 2.849